Cargando…

Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial

BACKGROUND: Contrast-induced nephropathy (CIN) is one of the most important complications of angiography in patients with chronic kidney disease (CKD) or diabetes mellitus. The prevention of CIN can decrease therapeutic costs and hospital stays. There is controversy in the literature over the preven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khosravi, Arezoo, Dolatkhah, Mitra, Hashemi, Hesam Sadat, Rostami, Zohreh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983115/ https://www.ncbi.nlm.nih.gov/pubmed/27570749 http://dx.doi.org/10.5812/numonthly.29574

Ejemplares similares

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
por: Bidram, Peyman, et al.
Publicado: (2015)

Efficacy of Atorvastatin in Prevention of Contrast-induced Nephropathy in High-risk Patients Undergoing Angiography: A Double-blind Randomized Controlled Trial
por: Syed, Maaz Hussain, et al.
Publicado: (2017)

To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia
por: Agrawal, Deepak, et al.
Publicado: (2018)

Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography
por: Sanei, Hamid, et al.
Publicado: (2014)

Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study
por: Lee, Seung-Ah, et al.
Publicado: (2023)

Effects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial
por: Sayyah, Mehdi, et al.
Publicado: (2015)

Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial
por: Ganji, Reza, et al.
Publicado: (2021)

Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction
por: Tunçez, Abdullah, et al.
Publicado: (2019)

Atorvastatin facilitates protection against contrast-induced nephropathy in patients undergoing coronary angiography via humoral mediators rather than altered renal hemodynamics
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Contrast-induced nephropathy following angiography and cardiac interventions
por: Rear, Roger, et al.
Publicado: (2016)

The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial
por: Gholoobi, Arash, et al.
Publicado: (2015)

Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)
por: Patel, Jaimin M, et al.
Publicado: (2012)

Comparison of Normal Saline, Ringer's Lactate, and Sodium Bicarbonate for Prevention of Contrast-induced Nephropathy in Patients with Coronary Angiography: A Randomized Double-blind Clinical Trial
por: Pakfetrat, Maryam, et al.
Publicado: (2019)

Optical coherence tomography angiography in intermediate uveitis-related cystoid macular edema
por: Alizadeh Ghavidel, Leila, et al.
Publicado: (2022)

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
por: Hing Ling, Paul Kah, et al.
Publicado: (2012)

Comparing common doses (double-dose vs usual-dose) of atorvastatin for preventing contrast-induced acute kidney injury and mortality after coronary angiography
por: Bei, Wei-Jie, et al.
Publicado: (2017)

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
por: Lee, Ji Hwan, et al.
Publicado: (2017)

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial
por: Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group
Publicado: (2010)

Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro
por: He, Xuyu, et al.
Publicado: (2017)

Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin
por: Golshani, Samad, et al.
Publicado: (2022)

Comparing Trimetazidine with Allopurinol in Prevention of Contrast Induced Nephropathy After Coronary Angiography
por: Galal, Haitham, et al.
Publicado: (2020)

Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
por: Moini, Abdollatif, et al.
Publicado: (2012)

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018)

Impact of atorvastatin reload on the prevention of contrast-induced nephropathy in patients on chronic statin therapy: A prospective randomized trial
por: Hammami, Rania, et al.
Publicado: (2023)

Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
por: Cho, Eun Joo, et al.
Publicado: (2023)

Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography
por: Assareh, Ahmadreza, et al.
Publicado: (2016)

Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
por: Davoodi, Lotfollah, et al.
Publicado: (2021)

Near Field Differential Interference Contrast Microscopy
por: Heydarian, Hesam, et al.
Publicado: (2020)

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
por: Constance, Christian, et al.
Publicado: (2014)

Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial
por: Bell, Robert M., et al.
Publicado: (2013)

Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice
por: Zeyghami, Mohammad Ali, et al.
Publicado: (2020)

The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension
por: Higaki, Jitsuo, et al.
Publicado: (2017)

Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial
por: Bays, Harold, et al.
Publicado: (2013)

Comparison of the effect of 40 and 80 mg/day doses of atorvastatin on changes in lipid profiles among acute coronary syndrome patients: A randomized clinical trial study
por: Sahebkar, Mohammad, et al.
Publicado: (2023)

Comparison of the Efficacy of Rosuvastatin versus Atorvastatin in Preventing Contrast Induced Nephropathy in Patient with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2014)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Significance of Cystatin C for Early Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography
por: Wang, Mian, et al.
Publicado: (2016)

Association between plasma endothelial microparticles and contrast-induced nephropathy in patients underwent coronary angiography
por: Fu, Xiaodan, et al.
Publicado: (2021)

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
por: Takazakura, Akiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tl2mvdvaqrr096i36lguaocfq0